NCT05298150Completed
Remote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 7 Jul 2026
Brief summary (registry, in English)
This research will develop novel and accessible way to deliver effective and customized rehab to those suffering from common and devastating neurodegenerative condition called Parkinson's disease. The investigators will examine the efficacy of novel rehab technique that can be monitored and modified in real-time but over virtual interface using a remotely located device in a paradigm called dynamic cycling. This technology will benefit thousands of Veterans who need customized and cost-effective rehab but cannot travel to specialized facilities due to inevitable limitations such as pandemics or because of lack of resources, social support, frailty, or home-bound status.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 8 Mar 2022
- Start date
- 1 Apr 2022
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- VA Office of Research and Development
- Diseases
- Parkinson disease
- NCT number
- NCT05298150
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 Apr 2022 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinical diagnosis including perinatal brain injury, stroke, and atypical parkinsonism
- One or more signs or symptoms of untreated cardiovascular disease including Pain, discomfort in the chest, neck, jaw, arms or other areas that may result from ischemia - Shortness of breath at rest or with mild exertion - Dizziness or syncope - Orthopnea or paroxysmal nocturnal dyspnea - Ankle edema - Palpitations or tachycardia - Intermittent claudication - heart murmur - Unusual fatigue or shortness of breath with usual activity (ACSM Cardiovascular Risk Assessment)
Other
- Montreal Cognitive Assessment Scoreless than 18
- Hamilton depression score of 20 or higher
- Hamilton anxiety rating score greater than 24
Who the study is looking for
- Diagnosis of PD using the UK Brain Bank criteria
- Ability to perform informed consent.
- Hoehn and Yahr (H\&Y) stages I-III when off medication,
- Stable medical regimen of antiparkinsonian medication for at least six months
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Louis Stokes VA Medical Center, Cleveland, OH Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.